Medication info

Cotrim Injection

Prescription medicationIntravenous injectionApproval withdrawn
Ingredient · strength
Sulfamethoxazole›80mg / 1mLTrimethoprim›16mg / 1mL
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
A colorless and transparent liquid filled in a brown ampoule
Packaging
5mL/ampoule X 10
Approval status
Approval withdrawn

MFDS item code 200606446 · Notified 2006.10.27

This product's status changed to Approval withdrawn on 2024.02.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of respiratory and ear, nose, and throat infections, genitourinary infections, and intestinal infections
Who receives it
Adults · Children
Adult administration
Adults and children 12 years of age and older Administer 10 mL per dose by intravenous drip infusion twice daily, every 12 hours. For severe infections, administer 15 mL per dose. Patients with renal impairment Creatinine clearance (mL/min) 30 or more: Normal dose Creatinine clearance (mL/min) 15~30: 1/2 of the normal dose Creatinine clearance (mL/min) 15 or less: Administration is not recommended Pneumocystis carinii pneumonia Administer trimethoprim 20 mg and sulfamethoxazole 100 mg per kg of body weight in 4 divided doses daily for 14 days. Do not administer the normal dose for more than 5 consecutive days, or the maximum dose for more than 3 consecutive days. Adjust the dose appropriately according to age and symptoms. Preparation and administration of this medicine Dilute at a ratio of 5 mL of this medicine to 125 mL of 5% glucose injection. Do not refrigerate after dilution and use within 6 hours. If diluting at a ratio of 5 mL of this medicine to 100 mL of 5% glucose injection, use within 4 hours. If turbidity or crystals are visible in the solution after dilution, discard the infusion solution immediately and prepare a new dilution. For patients who need to restrict fluid intake, dilute at a ratio of 5 mL of this medicine to 75 mL of glucose injection and use within 2 hours. Administer slowly by intravenous drip infusion over 60~90 minutes; rapid intravenous injection (bolus injection) should be avoided.
Child administration
Children under 12 years Administer trimethoprim 6 mg and sulfamethoxazole 30 mg per kg of body weight per day in 2 divided doses. 6~11 years: 5 mL per dose, 2 times daily 6 months~5 years: 1.25 mL per dose, 2 times daily Do not administer to infants under 2 months of age.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear, nose, and throat infections, genitourinary infections, and intestinal infections

  • Acute/chronic bronchitis
  • bronchiectasis
  • pneumonia
  • sinusitis
  • otitis media
  • acute/chronic cystitis
  • pyelonephritis
  • urethritis
  • prostatitis
  • gonorrhea
  • typhoid fever
  • paratyphoid fever
View approved original text

This medication is effective against various bacterial infections. It is used for respiratory infections such as acute and chronic bronchitis, bronchiectasis, and pneumonia. It is also effective for upper respiratory infections, including sinusitis and otitis media. It helps treat urogenital infections such as acute and chronic cystitis, pyelonephritis, urethritis, prostatitis, and gonorrhea. It is used for treating intestinal infections such as typhoid fever, paratyphoid fever, enteritis, and bacillary dysentery. This medication is used for treating infections caused by various bacteria.

How it is given

Adult administration

Adults and children 12 years of age and older Administer 10 mL per dose by intravenous drip infusion twice daily, every 12 hours. For severe infections, administer 15 mL per dose. Patients with renal impairment Creatinine clearance (mL/min) 30 or more: Normal dose Creatinine clearance (mL/min) 15~30: 1/2 of the normal dose Creatinine clearance (mL/min) 15 or less: Administration is not recommended Pneumocystis carinii pneumonia Administer trimethoprim 20 mg and sulfamethoxazole 100 mg per kg of body weight in 4 divided doses daily for 14 days. Do not administer the normal dose for more than 5 consecutive days, or the maximum dose for more than 3 consecutive days. Adjust the dose appropriately according to age and symptoms. Preparation and administration of this medicine Dilute at a ratio of 5 mL of this medicine to 125 mL of 5% glucose injection. Do not refrigerate after dilution and use within 6 hours. If diluting at a ratio of 5 mL of this medicine to 100 mL of 5% glucose injection, use within 4 hours. If turbidity or crystals are visible in the solution after dilution, discard the infusion solution immediately and prepare a new dilution. For patients who need to restrict fluid intake, dilute at a ratio of 5 mL of this medicine to 75 mL of glucose injection and use within 2 hours. Administer slowly by intravenous drip infusion over 60~90 minutes; rapid intravenous injection (bolus injection) should be avoided.

Child administration

Children under 12 years Administer trimethoprim 6 mg and sulfamethoxazole 30 mg per kg of body weight per day in 2 divided doses. 6~11 years: 5 mL per dose, 2 times daily 6 months~5 years: 1.25 mL per dose, 2 times daily Do not administer to infants under 2 months of age.

Precautions

This medication can cause severe skin reactions and serious blood, liver, and kidney diseases. If any symptoms such as fever, skin rash, sore throat, or jaundice occur during use, discontinuation is required. This medication is not suitable for treating certain bacterial infections, and should not be used for treatment of streptococcal pharyngitis. When breaking the ampoule of the injection, glass fragments may contaminate the solution, so care must be taken when using it, especially in children and the elderly. The preservatives contained in this medication can cause allergic reactions or exacerbation of asthma in some patients, so caution is necessary. Propylene glycol, the solvent ingredient, may cause kidney damage or central nervous system abnormalities when administered in high doses, so dosage and patient condition must be closely monitored. Benzyl alcohol, which is added, can cause fatal respiratory problems in premature infants, so it should not be given to newborns or premature babies. Those with hypersensitivity to this medication, pregnant women, newborns, and patients with certain blood disorders should not be administered this medication, and it should be used cautiously in patients with significantly impaired liver or kidney function. During administration, regular blood tests and liver and kidney function tests should be conducted to detect adverse reactions early and respond appropriately. There are many drug interactions with this medication, especially with anticoagulants, antidiabetic drugs, and immunosuppressants, so it is necessary to verify concurrent use with other medications. Pregnant or lactating women should not use this medication, and it is also unsafe to administer it to newborns and infants. Elderly patients should have careful dosage adjustments and monitoring due to the risk of drug accumulation in the body caused by decreased kidney function. Overdose may lead to symptoms such as vomiting, diarrhea, confusion, and blood abnormalities, and in such cases, immediate notification to medical personnel is required for appropriate treatment. If the injection solution leaks outside the blood vessel, it may cause local inflammation, so the injection site must be carefully monitored, and if any abnormalities are found, the injection should be stopped and moved to a different site. This medication carries a risk of serious side effects when used for prolonged periods or in high doses, and it should only be administered for the minimum duration necessary with ongoing monitoring of the patient’s condition.

Side effects

Severe skin adverse reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reactions associated with eosinophilia and systemic symptoms, acute febrile neutrophilic dermatosis, acute generalized pustular psoriasis, fulminant hepatic necrosis, agranulocytosis, aplastic anemia, other blood disorders, respiratory hypersensitivity reactions, anaphylaxis, sore throat, fever, arthralgia, cough, dyspnea, pallor, purpura, jaundice, neutropenia, hemolytic anemia, pancytopenia, thrombocytopenia, leukopenia, macrocytic anemia, methemoglobinemia, neutropenia, hypoprothrombinemia, eosinophilia, shock, malaise, oral dysesthesia, wheezing, dizziness, diarrhea, tinnitus, sweating, conjunctival and scleral injection, rash, itching, candidiasis, erythema, blisters, urticaria, phototoxic reactions, exfoliative dermatitis, systemic lupus erythematosus, severe liver dysfunction, AST/ALT elevation, ALP elevation, γ-GTP elevation, jaundice, elevated serum bilirubin, hepatitis, hepatic necrosis, polyuria, anuria, toxic nephropathy, acute kidney failure, renal impairment, hematuria, interstitial nephritis, crystalluria, increased diuresis, forgetfulness, weakness, fatigue, insomnia, headache, peripheral neuropathy, drowsiness, ataxia, seizures, aseptic meningitis, meningitis-like symptoms, paralysis, myasthenia, fatigue, depression, hallucinations, transient myopia, acute eosinophilic pneumonia, acute respiratory failure, eosinophilia, abnormal chest X-ray findings, eosinophilic pulmonary infiltration, interstitial pneumonia, gastrointestinal disorders, loss of appetite, nausea, vomiting, diarrhea, abdominal pain, upper abdominal discomfort, glossitis, angular cheilitis, stomatitis, cholestasis, hematochezia, constipation, thirst, gingivitis, dysgeusia, hypoglycemia, arthralgia, myalgia, ventricular tachycardia, torsades de pointes, localized reactions, pain, slight irritation, thrombophlebitis, uveitis, fever, heat sensation, hypertension, hypotension, palpitations, chest discomfort, facial flushing, edema, hemoglobinuria, hypokalemia, metabolic acidosis, pseudosepsis, fever, vascular edema, serum sickness, nodular periarteritis, allergic myocarditis, hyperkalemia, hyponatremia, myalgia, weakness, CK elevation, elevated serum and urine myoglobin levels, rhabdomyolysis, rapid deterioration of kidney function, acute kidney failure, superinfection, sperm production inhibition, nausea, vomiting, diarrhea, headache, tinnitus, dizziness, confusion, loss of appetite, drowsiness, unconsciousness, jaundice, depression, delirium, crystalluria, hematuria, anuria, thrombocytopenia, leukopenia, bone marrow suppression, folate deficiency symptoms

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that does not allow light in. It should be stored at room temperature, ideally between 1 and 30 degrees Celsius, in order to maintain the medication's effectiveness for a longer time.

Appearance and packaging

Appearance

A colorless and transparent liquid filled in a brown ampoule

Package unit

5mL/ampoule X 10

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.